We analyzed the publicly available BEAT-AML database, which contains predominately cases of de novo AML, and stratified patients to the top and bottom quartile of FBXO11 expression based on RPKM values from RNA-sequencing studies19. The gene discussed is FBXO11; the disease is acute myeloid leukemia.